Fulgent Genetics, Inc. - Common Stock (FLGT)

Competitors to Fulgent Genetics, Inc. - Common Stock (FLGT)

Ambry Genetics

Ambry Genetics specializes in genetic and genomic testing, competing directly with Fulgent Genetics in offering tests for hereditary conditions and cancer risk assessment. Ambry is known for innovative testing and has a strong focus on genetic counseling, which enhances their customer experience and outcomes. While Ambry is a privately-held entity, its established reputation and extensive test menus could provide it with a competitive advantage, making it a formidable competitor as Fulgent seeks to expand its comprehensive testing capabilities and customer outreach.

Invitae Corporation

Fulgent Genetics and Invitae Corporation both operate in the genetic testing and diagnostics market, focusing on providing advanced testing solutions for inherited conditions, cancer, and other diseases. Invitae offers a range of genetic tests and has a larger portfolio compared to Fulgent, giving it wider market reach and brand recognition. Furthermore, Invitae's aggressive diversification strategy and partnerships may offer it an edge in terms of innovation and product offerings, allowing it to compete strongly in genetic testing, although both companies aim for personalized healthcare solutions.

Myriad Genetics, Inc. 

Myriad Genetics specializes in genetic testing and has a strong focus on precision medicine, similar to Fulgent Genetics. Both companies provide tests aimed at assessing disease risk and treatment efficacy. However, Myriad has an established market presence with a comprehensive suite of tests as well as strong relationships with healthcare providers, giving it a competitive edge in terms of market share and trust within the medical community. This established position can make it challenging for Fulgent to gain the same level of recognition and adoption in clinical settings.

Natera, Inc. 

Natera provides genetic testing solutions that include non-invasive prenatal testing (NIPT) and oncology testing, similar to some of Fulgent's offerings. Both companies leverage cutting-edge technology in genetic testing; however, Natera's focus on reproductive health and oncology gives it a specialized niche that sets it apart. Natera's strong sales and marketing strategy, combined with a well-recognized brand, allow it to compete effectively against Fulgent, which must continue to innovate and expand its own specialties to match Natera's targeted market success.